All In Biotech

Drug Trial Radar · NCT07535775

Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers

A Phase Ib, Open-Label Study Investigating the Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers

Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

May 11, 2026

Primary completion

Oct 10, 2026

Study completion Mar 20, 2027

Sponsor

Lead sponsor
SPH-BIOCAD (HK) LimitedIndustry
Sponsor type
Industry
First posted
Apr 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 after Single Subcutaneous Injection in Healthy Chinese Volunteers

Conditions

  • Healthy Adult Participants

Interventions

  • BCD-261Drug

    Anti-TL1A human monoclonal antibody. Solution for Subcutaneous Injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. proportion of subjects with serious adverse eventsTime frame: 309days
  2. proportion of subjects with adverse eventsTime frame: 309days
  3. proportion of subjects with CTCAE grade 3 or higher adverse eventsTime frame: 309days
  4. proportion of subjects who prematurely withdrew from the study due to adverse events.Time frame: 309days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Huashan Hospital, Fudan University

    Shanghai, Shanghai Municipality, China

  • Huashan Hospital, Fudan University

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.